Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Related Articles by Review for PubMed (Select 23155683)

1.

18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.

Yang J, Yuan L, Meeks JK, Zhang N, Li C, Hao R.

J Pediatr Endocrinol Metab. 2012;25(7-8):619-22. Review.

PMID:
23155683
2.

[18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism.

Mohnike K, Blankenstein O, Minn H, Mohnike W, Fuchtner F, Otonkoski T.

Horm Res. 2008;70(2):65-72. doi: 10.1159/000137655. Epub 2008 Jun 12. Review.

PMID:
18547951
3.

Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.

Treglia G, Mirk P, Giordano A, Rufini V.

Pediatr Radiol. 2012 Nov;42(11):1372-9. doi: 10.1007/s00247-012-2459-2. Epub 2012 Aug 12. Review.

PMID:
22885604
4.

Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.

Ismail D, Hussain K.

Rev Endocr Metab Disord. 2010 Sep;11(3):165-9. doi: 10.1007/s11154-010-9145-1. Review.

PMID:
20878481
5.

The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis.

Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A.

Mol Imaging Biol. 2013 Feb;15(1):97-105. doi: 10.1007/s11307-012-0572-0. Review.

6.

¹⁸F-DOPA PET/computed tomography imaging.

Chondrogiannis S, Marzola MC, Rubello D.

PET Clin. 2014 Jul;9(3):307-21. doi: 10.1016/j.cpet.2014.03.007. Epub 2014 Apr 29. Review.

PMID:
25030394
7.

Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.

Calabria F, Chiaravalloti A, Di Pietro B, Grasso C, Schillaci O.

Nucl Med Commun. 2012 Jun;33(6):563-70. doi: 10.1097/MNM.0b013e328351d566. Review.

PMID:
22395034
8.

Congenital hyperinsulinism: current trends in diagnosis and therapy.

Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, Brunelle F, Fournet JC, Robert JJ, Aigrain Y, Bellanné-Chantelot C, de Lonlay P.

Orphanet J Rare Dis. 2011 Oct 3;6:63. doi: 10.1186/1750-1172-6-63. Review.

9.

Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.

Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K, Koopmans KP, Minn H, Mohnike W, Mutair A, Otonkoski T, Rahier J, Ribeiro M, Schoenle E, Fékété CN.

Horm Res. 2006;66(1):40-2. Epub 2006 May 19. No abstract available.

PMID:
16710094
10.

Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.

Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, Rufini V, Giordano A.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1144-53. doi: 10.1007/s00259-012-2087-y. Epub 2012 Feb 23. Review.

PMID:
22358431
11.

[Radiological innovations in the screening and diagnosis of the inborn errors of metabolism].

Boddaert N, Ribeiro M, Touati G, Mention K, Valayanopoulos V, Nihoul-Fékété C, Brunelle F, de Lonlay P.

Med Sci (Paris). 2005 Nov;21(11):981-6. Review. French.

12.

Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism.

Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove KE, Clayton PE, Dunne MJ.

Clin Endocrinol (Oxf). 2013 Jun;78(6):803-13. doi: 10.1111/cen.12153. Review.

PMID:
23347463
13.

Persistent hyperinsulinaemic hypoglycaemia in infancy.

Shah P, Demirbilek H, Hussain K.

Semin Pediatr Surg. 2014 Apr;23(2):76-82. doi: 10.1053/j.sempedsurg.2014.03.005. Epub 2014 Mar 15. Review.

PMID:
24931352
14.

Congenital hyperinsulinism: Role of fluorine-18L-3, 4 hydroxyphenylalanine positron emission tomography scanning.

Gopal-Kothandapani JS, Hussain K.

World J Radiol. 2014 Jun 28;6(6):252-60. doi: 10.4329/wjr.v6.i6.252. Review.

15.

[Congenital hyperinsulinism--diagnosis and treatment].

Christesen HT, Bruun MF, Christoffersen SH, Rasmussen L, Petersen H, Detlefsen S, Hovendal CP, Hansen TG, Hansen TP, Brusgaard K.

Ugeskr Laeger. 2011 Nov 21;173(47):3020-5. Review. Danish.

PMID:
22118585
16.

Surgical management of congenital hyperinsulinism of infancy.

Pierro A, Nah SA.

Semin Pediatr Surg. 2011 Feb;20(1):50-3. doi: 10.1053/j.sempedsurg.2010.10.009. Review.

PMID:
21186005
17.

Techniques in pediatric surgery: congenital hyperinsulinism.

Barthlen W, Mohnike W, Mohnike K.

Horm Res Paediatr. 2011;75(4):304-10. doi: 10.1159/000323532. Epub 2011 Feb 16. Review.

PMID:
21325787
18.

6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.

Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP, Gulenchyn KY.

J Nucl Med. 2008 Apr;49(4):573-86. doi: 10.2967/jnumed.107.045708. Epub 2008 Mar 14. Review.

19.

Role of [18F]-dopa-PET imaging in assessing movement disorders.

Fischman AJ.

Radiol Clin North Am. 2005 Jan;43(1):93-106. Review.

PMID:
15693650
20.

Congenital hyperinsulinism.

Arnoux JB, de Lonlay P, Ribeiro MJ, Hussain K, Blankenstein O, Mohnike K, Valayannopoulos V, Robert JJ, Rahier J, Sempoux C, Bellanné C, Verkarre V, Aigrain Y, Jaubert F, Brunelle F, Nihoul-Fékété C.

Early Hum Dev. 2010 May;86(5):287-94. doi: 10.1016/j.earlhumdev.2010.05.003. Epub 2010 Jun 13. Review.

PMID:
20550977
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk